Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib.
Vikram MalhiNageshwar BudhaRucha SaneJian HuangBianca LiedererRaymond MengPremal PatelYuzhong DengAndres CervantesJosep TaberneroLuna MusibPublished in: Cancer chemotherapy and pharmacology (2021)
NCT01090960 (registered March 23, 2010); NCT02536391 (registered August 31, 2015).